Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.
After four years of negotiation, the European Parliament has published the text of its EU Medical Device Regulation (MDR), setting the stage for sweeping changes across the medical device value chain.
As expected, medtechs will bear the brunt of the costs of complying with the new regulation. To reduce the costs - and execution hazards - associated with implementation, we recommend companies take a risk-based approach to compliance that involves a detailed assessment of the revenue impact, as well as the cost and complexity of remediation. By outlining a thoughtful, well-ordered approach now, medtechs can protect valuable and future revenues while making upgrades to critical business functions.
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!
Improving orthopaedic care, education and research using Internet technologies